SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Abhishek Maiti, Robert E. Brown, Paul G. Corn, Ravi Murthy, Dhakshina Moorthy Ganeshan, Apostolia M. Tsimberidou, Vivek Subbiah, Antitumor Response to Combined Antiangiogenic and Cytotoxic Chemotherapy in Recurrent Metastatic Chromophobe Renal Cell Carcinoma: Response Signatures and Proteomic Correlates, Clinical Genitourinary Cancer, 2016, 14, 2, e187

    CrossRef

  2. 2
    Nizar M. Tannir, Eric Jonasch, Laurence Albiges, Emre Altinmakas, Chaan S. Ng, Surena F. Matin, Xuemei Wang, Wei Qiao, Zita Dubauskas Lim, Pheroze Tamboli, Priya Rao, Kanishka Sircar, Jose A. Karam, David F. McDermott, Christopher G. Wood, Toni K. Choueiri, Everolimus Versus Sunitinib Prospective Evaluation in Metastatic Non–Clear Cell Renal Cell Carcinoma (ESPN): A Randomized Multicenter Phase 2 Trial, European Urology, 2016, 69, 5, 866

    CrossRef

  3. 3
    Andrea Coinu, Fausto Petrelli, Sandro Barni, Optimal treatment of poor-risk renal cell carcinoma patients with mTOR inhibitors and anti-VEGFR agents, Expert Review of Anticancer Therapy, 2016, 16, 1, 33

    CrossRef

  4. 4
    Laurence Albiges, Toni Choueiri, Bernard Escudier, Matthew Galsky, Dan George, Fabian Hofmann, Thomas Lam, Robert Motzer, Peter Mulders, Camillo Porta, Thomas Powles, Cora Sternberg, Axel Bex, A Systematic Review of Sequencing and Combinations of Systemic Therapy in Metastatic Renal Cancer, European Urology, 2015, 67, 1, 100

    CrossRef

  5. 5
    Nils Kroeger, Allan J. Pantuck, J. Connor Wells, Nicola Lawrence, Reuben Broom, Jenny J. Kim, Sandy Srinivas, Jessica Yim, Georg A. Bjarnason, Arnoud Templeton, Jennifer Knox, Ezra Bernstein, Martin Smoragiewicz, Jae Lee, Brian I. Rini, Ulka N. Vaishampayan, Lori A. Wood, Benoit Beuselinck, Frede Donskov, Toni K. Choueiri, Daniel Y. Heng, Characterizing the Impact of Lymph Node Metastases on the Survival Outcome for Metastatic Renal Cell Carcinoma Patients Treated with Targeted Therapies, European Urology, 2015, 68, 3, 506

    CrossRef

  6. 6
    Laurence Albiges, Bernard Escudier, Current and future strategies in nonclear-cell metastatic renal cell carcinoma, Current Opinion in Urology, 2015, 25, 5, 367

    CrossRef

  7. 7
    Laurence Albiges, André P. Fay, Rana R. McKay, Marina D. Kaymakcalan, Toni K. Choueiri, Diagnosis of Renal Cell Carcinoma, Surgical Pathology Clinics, 2015, 8, 4, 657

    CrossRef

  8. 8
    Sonia Vallet, Sascha Pahernik, Thomas Höfner, Georgi Tosev, Boris Hadaschik, Stefan Duensing, Oliver Sedlaczek, Markus Hohenfellner, Dirk Jäger, Carsten Grüllich, Efficacy of Targeted Treatment Beyond Third-Line Therapy in Metastatic Kidney Cancer: Retrospective Analysis From a Large-Volume Cancer Center, Clinical Genitourinary Cancer, 2015, 13, 3, e145

    CrossRef

  9. 9
    Susanne M. Rittig, Maik Haentschel, Katrin J. Weimer, Annkristin Heine, Martin R. Müller, Wolfram Brugger, Marius S Horger, Olga Maksimovic, Arnulf Stenzl, Ingmar Hoerr, Hans-Georg Rammensee, Tobias A. Holderried, Lothar Kanz, Steve Pascolo, Peter Brossart, Long-term survival correlates with immunological responses in renal cell carcinoma patients treated with mRNA-based immunotherapy, OncoImmunology, 2015, e1108511

    CrossRef

  10. 10
    Daniel Su, Eric A. Singer, Ramaprasad Srinivasan, Molecular pathways in renal cell carcinoma, Current Opinion in Oncology, 2015, 27, 3, 217

    CrossRef

  11. 11
    Chiara Ciccarese, Francesco Massari, Matteo Santoni, Daniel Y.C. Heng, Valeria Sotte, Matteo Brunelli, Alessandro Conti, Liang Cheng, Antonio Lopez-Beltran, Marina Scarpelli, Stefano Cascinu, Giampaolo Tortora, Rodolfo Montironi, New molecular targets in non clear renal cell carcinoma: An overview of ongoing clinical trials, Cancer Treatment Reviews, 2015, 41, 7, 614

    CrossRef

  12. 12
    Mian Xie, Chao sheng He, Jin Kun Huang, Qi zhan Lin, Phase II study of pazopanib as second-line treatment after sunitinib in patients with metastatic renal cell carcinoma: A Southern China Urology Cancer Consortium Trial, European Journal of Cancer, 2015, 51, 5, 595

    CrossRef

  13. 13
    Nobuo Shinohara, Takashige Abe, Prognostic factors and risk classifications for patients with metastatic renal cell carcinoma, International Journal of Urology, 2015, 22, 10
  14. 14
    Michael K Wong, Eric Jonasch, Sumanta K Pal, James E Signorovitch, Peggy L Lin, Xufang Wang, Zhimei Liu, Ken Culver, Jeffrey A Scott, Daniel J George, Nicholas J Vogelzang, Prognostic factors for survival following initiation of second-line treatment with everolimus for metastatic renal cell carcinoma: evidence from a nationwide sample of clinical practice in the United States, Expert Opinion on Pharmacotherapy, 2015, 16, 6, 805

    CrossRef

  15. 15
    Raquibul Hannan, Vitaly Margulis, Stephen G Chun, Nathan Cannon, D W Nathan Kim, Ramzi E Abdulrahman, Arthur Sagalowsky, Ivan Pedrosa, Hak Choy, James Brugarolas, Robert D Timmerman, Stereotactic radiation therapy of renal cancer inferior vena cava tumor thrombus, Cancer Biology & Therapy, 2015, 16, 5, 657

    CrossRef

  16. 16
    Jenny J Ko, Wanling Xie, Nils Kroeger, Jae-lyun Lee, Brian I Rini, Jennifer J Knox, Georg A Bjarnason, Sandy Srinivas, Sumanta K Pal, Takeshi Yuasa, Martin Smoragiewicz, Frede Donskov, Ravindran Kanesvaran, Lori Wood, D Scott Ernst, Neeraj Agarwal, Ulka N Vaishampayan, Sun-young Rha, Toni K Choueiri, Daniel Y C Heng, The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study, The Lancet Oncology, 2015, 16, 3, 293

    CrossRef

  17. 17
    Sebastian L. Hofbauer, Allan J. Pantuck, Michela de Martino, Ilaria Lucca, Andrea Haitel, Shahrokh F. Shariat, Arie S. Belldegrun, Tobias Klatte, The preoperative prognostic nutritional index is an independent predictor of survival in patients with renal cell carcinoma, Urologic Oncology: Seminars and Original Investigations, 2015, 33, 2, 68.e1

    CrossRef

  18. 18
    Haoran Li, Haider Samawi, Daniel Y.C. Heng, The use of prognostic factors in metastatic renal cell carcinoma, Urologic Oncology: Seminars and Original Investigations, 2015, 33, 12, 509

    CrossRef

  19. 19
    Brian Shuch, Ali Amin, Andrew J. Armstrong, John N. Eble, Vincenzo Ficarra, Antonio Lopez-Beltran, Guido Martignoni, Brian I. Rini, Alexander Kutikov, Understanding Pathologic Variants of Renal Cell Carcinoma: Distilling Therapeutic Opportunities from Biologic Complexity, European Urology, 2015, 67, 1, 85

    CrossRef

  20. 20
    Annette Zimpfer, Stephanie Janke, Maja Hühns, Björn Schneider, Günther Kundt, Heike Zettl, Ergin Kilic, Matthias Maruschke, Oliver W. Hakenberg, Andreas Erbersdobler, C-kit overexpression is not associated with KIT gene mutations in chromophobe renal cell carcinoma or renal oncocytoma, Pathology - Research and Practice, 2014, 210, 8, 521

    CrossRef

  21. You have free access to this content21
    Richard Lee-Ying, Renee Lester, Daniel YC Heng, Current management and future perspectives of metastatic renal cell carcinoma, International Journal of Urology, 2014, 21, 9
  22. You have free access to this content22
    Takeshi Yuasa, Editorial Comment to Localized non-conventional renal cell carcinoma: Prediction of clinical outcome according to histology, International Journal of Urology, 2014, 21, 4
  23. 23
    Anne V. Soerensen, Frede Donskov, Gregers G. Hermann, Niels V. Jensen, Astrid Petersen, Henrik Spliid, Rickard Sandin, Kirsten Fode, Poul F. Geertsen, Improved overall survival after implementation of targeted therapy for patients with metastatic renal cell carcinoma: Results from the Danish Renal Cancer Group (DARENCA) study-2, European Journal of Cancer, 2014, 50, 3, 553

    CrossRef

  24. 24
    S L Hofbauer, K I Stangl, M de Martino, I Lucca, A Haitel, S F Shariat, T Klatte, Pretherapeutic gamma-glutamyltransferase is an independent prognostic factor for patients with renal cell carcinoma, British Journal of Cancer, 2014, 111, 8, 1526

    CrossRef

  25. 25
    Daniel Su, Lambros Stamatakis, Eric A. Singer, Ramaprasad Srinivasan, Renal cell carcinoma, Current Opinion in Oncology, 2014, 26, 3, 321

    CrossRef

  26. 26
    Laura-Maria Krabbe, Ahmed Q. Haddad, Mary E. Westerman, Vitaly Margulis, Surgical management of metastatic renal cell carcinoma in the era of targeted therapies, World Journal of Urology, 2014, 32, 3, 615

    CrossRef

  27. 27
    Nils Kroeger, Toni K. Choueiri, Jae-Lyn Lee, Georg A. Bjarnason, Jennifer J. Knox, Mary J. MacKenzie, Lori Wood, Sandy Srinivas, Ulka N. Vaishamayan, Sun-Young Rha, Sumanta K. Pal, Takeshi Yuasa, Frede Donskov, Neeraj Agarwal, Min-Han Tan, Aristotelis Bamias, Christian K. Kollmannsberger, Scott A. North, Brian I. Rini, Daniel Y.C. Heng, Survival Outcome and Treatment Response of Patients with Late Relapse from Renal Cell Carcinoma in the Era of Targeted Therapy, European Urology, 2014, 65, 6, 1086

    CrossRef